{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T20:27:17Z","timestamp":1749155237209},"reference-count":10,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2012,6,7]],"date-time":"2012-06-07T00:00:00Z","timestamp":1339027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics and Practice"],"abstract":"<jats:p>A 58-year-old Caucasian male presented to the urology clinic reporting an approximate one-year history of a persistent irritating, slowly progressive, glans penis redness. Biopsy revealed penile squamous cell carcinoma in situ. He underwent a partial glansectomy with circumcision and skin grafting. At three months follow-up there is no evidence of local disease recurrence. In western countries, primary malignant penile cancer is uncommon, with an incidence of less than 1 per 100,000 males. Squamous cell cancer accounts for more than 95% of cases of penile cancer. Squamous cell carcinoma in situ on the penile mucosa or transitional surfaces is also known as Erythroplasia of Queyrat. In the region, one third of penile squamous cell carcinoma in situ cases progress to invasive squamous cell carcinoma.<\/jats:p>","DOI":"10.4081\/cp.2012.e63","type":"journal-article","created":{"date-parts":[[2012,6,7]],"date-time":"2012-06-07T16:53:15Z","timestamp":1339087995000},"page":"e63","source":"Crossref","is-referenced-by-count":7,"title":["Erythroplasia of Queyrat"],"prefix":"10.3390","volume":"2","author":[{"given":"Deirdre Mary","family":"Fanning","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugh","family":"Flood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2012,6,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.urolonc.2006.08.029","article-title":"Incidence trends in primary malignant penile cancer","volume":"25","author":"Barnholtz-Sloan","year":"2007","journal-title":"Urol Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1470-2045(04)01427-5","article-title":"Penile carcinoma: a challenge for the developing world","volume":"5","author":"Misra","year":"2004","journal-title":"Lancet Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jaad.2005.05.007","article-title":"Penile cancer","volume":"54","author":"Micali","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/106689690401200207","article-title":"Limitations in the interpretation of biopsies in patients with penile squamous cell carcinoma","volume":"12","author":"Velazquez","year":"2004","journal-title":"Int J Surg Pathol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1523-1747.2000.00069.x","article-title":"Erythroplasia of queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ","volume":"115","author":"Wieland","year":"2000","journal-title":"J Invest Dermatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0022-5347(17)35099-1","article-title":"Carcinoma in situ of the penis","volume":"151","author":"Gerber","year":"1994","journal-title":"J Urol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jaad.2006.07.021","article-title":"Erythroplasia of Queyrat treated with imiquimod 5% cream","volume":"55","author":"Micali","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1468-3083.2005.01217.x","article-title":"Carbon dioxide laser treatment of erythroplasia of Queyrat: a revisited treatment to this condition","volume":"19","author":"Conejo-Mir","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1464-410X.2005.05769.x","article-title":"What surgical resection margins are required to achieve oncological control in men with primary penile cancer?","volume":"96","author":"Minhas","year":"2005","journal-title":"BJU Int"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1464-410X.2006.06368.x","article-title":"Total glans resurfacing for premalignant lesions of the penis: initial outcome data","volume":"98","author":"Hadway","year":"2006","journal-title":"BJU Int"}],"container-title":["Clinics and Practice"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.clinicsandpractice.org\/index.php\/cp\/article\/viewFile\/488\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.mdpi.com\/2039-7283\/2\/3\/e63\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T06:14:31Z","timestamp":1644473671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2039-7283\/2\/3\/e63"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,7]]},"references-count":10,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,10]]}},"alternative-id":["cp.2012.e63"],"URL":"https:\/\/doi.org\/10.4081\/cp.2012.e63","relation":{},"ISSN":["2039-7283"],"issn-type":[{"value":"2039-7283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,7]]}}}